Download presentation
Presentation is loading. Please wait.
Published bySharlene Dixon Modified over 8 years ago
1
EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme Bryan W. Day, Brett W. Stringer, Fares Al-Ejeh, Michael J. Ting, John Wilson, Kathleen S. Ensbey, Paul R. Jamieson, Zara C. Bruce, Yi Chieh Lim, Carolin Offenhäuser, Sara Charmsaz, Leanne T. Cooper, Jennifer K. Ellacott, Angus Harding, Lucie Leveque, Po Inglis, Suzanne Allan, David G. Walker, Martin Lackmann, Geoffrey Osborne, Kum Kum Khanna, Brent A. Reynolds, Jason D. Lickliter, Andrew W. Boyd Cancer Cell Volume 23, Issue 2, Pages 238-248 (February 2013) DOI: 10.1016/j.ccr.2013.01.007 Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
2
Figure 1 Cancer Cell 2013 23, 238-248DOI: (10.1016/j.ccr.2013.01.007) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
3
Figure 2 Cancer Cell 2013 23, 238-248DOI: (10.1016/j.ccr.2013.01.007) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
4
Figure 3 Cancer Cell 2013 23, 238-248DOI: (10.1016/j.ccr.2013.01.007) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
5
Figure 4 Cancer Cell 2013 23, 238-248DOI: (10.1016/j.ccr.2013.01.007) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
6
Figure 5 Cancer Cell 2013 23, 238-248DOI: (10.1016/j.ccr.2013.01.007) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
7
Figure 6 Cancer Cell 2013 23, 238-248DOI: (10.1016/j.ccr.2013.01.007) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.